Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Deventer

Showing results (241-250 of 273) with videos related to

Pageof 28
Sort By:
Blood|January 15, 1994
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzeesT van der Poll, M Levi, S J van Deventer, et al.
Blood|February 9, 2000
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemiaE de Jonge, P E Dekkers, A A Creasey, et al.
The Journal of Infectious Diseases|December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levelsC H Wortel, M A von der Möhlen, S J van Deventer, et al.
Clinical and Experimental Immunology|April 1, 1995
Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzeesT van der Poll, M Levi, H ten Cate, et al.
Thrombosis and Haemostasis|February 1, 1997
Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemiaD Pajkrt, P G Lerch, T van der Poll, et al.
The Journal of Experimental Medicine|April 1, 1994
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzeesT van der Poll, M Levi, C E Hack, et al.
Gene Therapy|August 4, 2017
AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's diseaseJ Miniarikova, V Zimmer, R Martier, et al.
Molecular Therapy. Nucleic Acids|March 23, 2016
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's DiseaseJana Miniarikova, Ilaria Zanella, Angelina Huseinovic, et al.
Brain Sciences|January 27, 2021
Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease PathologyElisabeth A Spronck, Astrid Vallès, Margit H Lampen, et al.
Gastroenterology|July 6, 2004
Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancerRogier E Van Gelder, C Yung Nio, Jasper Florie, et al.
Pageof 28

Showing results (241-250 of 273) with videos related to

Sort By:
Pageof 28
Blood|January 15, 1994
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzeesT van der Poll, M Levi, S J van Deventer, et al.
Blood|February 9, 2000
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemiaE de Jonge, P E Dekkers, A A Creasey, et al.
The Journal of Infectious Diseases|December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levelsC H Wortel, M A von der Möhlen, S J van Deventer, et al.
Clinical and Experimental Immunology|April 1, 1995
Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzeesT van der Poll, M Levi, H ten Cate, et al.
Thrombosis and Haemostasis|February 1, 1997
Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemiaD Pajkrt, P G Lerch, T van der Poll, et al.
The Journal of Experimental Medicine|April 1, 1994
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzeesT van der Poll, M Levi, C E Hack, et al.
Gene Therapy|August 4, 2017
AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's diseaseJ Miniarikova, V Zimmer, R Martier, et al.
Molecular Therapy. Nucleic Acids|March 23, 2016
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's DiseaseJana Miniarikova, Ilaria Zanella, Angelina Huseinovic, et al.
Brain Sciences|January 27, 2021
Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease PathologyElisabeth A Spronck, Astrid Vallès, Margit H Lampen, et al.
Gastroenterology|July 6, 2004
Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancerRogier E Van Gelder, C Yung Nio, Jasper Florie, et al.
Pageof 28